Please Wait...

An Intelligent Approach to Risk-Based Monitoring - On Demand Webinar

How People, Process and Tools can Improve Clinical Trial Quality

Duration: 1 hour

Complete form below to view the on-demand webinar >>

Many pharmaceutical companies are excited by the promise of Risk-Based Monitoring, but are uncertain as to how to implement such an initiative. In this insightful presentation, Courtney McBean will discuss the core principles of Risk-Based Monitoring and the key steps to Implementing an RBM program that goes beyond reducing site visits and instills a greater focus on quality in clinical trials.

The presentation will focus on the important role played by

  • People – Having the right people involved in your program is a must!
  • Process – Defining a repeatable plan is crucial – learn the 7 points that must be considered
  • Tools – Attendees will see firsthand how the right technology can help you monitor what matters, when it matters.

This is a must-see for any sponsor or CRO seeking to reduce costs, improve quality, and run more efficient clinical trials.

Courtney McBean is the Vice President of Clinical Innovation at BioClinica. She was a founder of Blueprint Clinical – the innovative company that created the Compass Intelligent Monitoring solution and was recognized by Gartner as a "2014 Cool Vendor in Life Sciences." Since BioClinica's May acquisition of Blueprint, Courtney and her team have doubled their efforts to challenge the pharmaceutical community to go beyond risk-based monitoring and embrace an Intelligent Monitoring approach to clinical trials that goes beyond reducing site monitoring visits to a focus on overall quality.

View all upcoming BioClinica webinars.

 

Please fill out the form below to view the On Demand Webinar.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Bioclinica is divided into three business segments so that we can provide expert service and multifaceted technologies. Our Medical Imaging and Biomarkers segment includes an Imaging Core Lab, a Cardiovascular Safety division, and a Biomarker Laboratory. Our eHealth segment comprises an eClinical Solutions Division along with Safety and Regulatory Solutions. Under the Global Clinical Research segment, we offer a network of research sites, patient recruitment, and a Post-Approval Research division.

NJ Statewide Career & Internship Fair is Friday, April 28! Talk w @BioclinicaJobs Proj Mgmt, BD, CDM, IT. Details… https://t.co/27LdT00OEo
bioclinica (5 hours ago)
eHealth Solutions president Mukhtar Ahmed is speaking at #Phorum17 on Apr. 27 https://t.co/OaBPodxZBF https://t.co/VO6GKV0a8v
bioclinica (6 hours ago)
Global Head of Risk-Based Monitoring Kristin Mauri on #RBM essential capabilities. Read the blog here https://t.co/z3yUGZqOzH
bioclinica (11 hours ago)
Guest column by Nancy Bradish Myers & Anne McNickle on the White House deregulatory landscape @MedDeviceOnline… https://t.co/LlCJtAPpWz
bioclinica (11 hours ago)
Kicking off day 2 Clinical Trial Innov. Summit! Patient recruitment, RBM, technology-enabled #ClinicaTrials r hot t… https://t.co/IoynV539R9
bioclinica (13 hours ago)
Join us in Philly nxt wk at #Biomarkers & Immuno #Oncology World Congress! Happy to answer Qs in any of these areas https://t.co/fJ5mVAfQTe
bioclinica (Yesterday)

Latest Blogs: